These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33126605)

  • 1. Associations of
    Chang JH; Lai TC; Yang PJ; Shih PC; Yang YC; Lee KL; Liu TC; Tsao TC; Yang SF; Chien MH
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Impacts of
    Lee KL; Lai TC; Wang YC; Shih PC; Yang YC; Tsao TC; Liu TC; Wen YC; Chang LC; Yang SF; Chien MH
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33802737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer.
    Su CW; Huang YW; Chen MK; Su SC; Yang SF; Lin CW
    Medicine (Baltimore); 2015 Nov; 94(46):e2092. PubMed ID: 26579821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship between Long Noncoding RNA H19 Polymorphism and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma.
    Wang YC; Tsao SM; Li YT; Lee CY; Tsao TC; Hsieh MJ; Yang SF
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33799753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
    Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
    Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Aurora Kinase A Polymorphism and Epithelial Growth Factor Receptor Mutations on the Clinicopathological Characteristics of Lung Adenocarcinoma.
    Yang PJ; Hsieh MJ; Lee CI; Yen CH; Wang HL; Chiang WL; Liu TC; Tsao TC; Lee CY; Yang SF
    Int J Environ Res Public Health; 2020 Oct; 17(19):. PubMed ID: 33050100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent DYRK2 gene amplification in micropapillary element of lung adenocarcinoma - an implication in progression in EGFR-mutated lung adenocarcinoma.
    Koike C; Okudela K; Matsumura M; Mitsui H; Suzuki T; Arai H; Kataoka T; Ishikawa Y; Umeda S; Tateishi Y; Ohashi K
    Histol Histopathol; 2021 Mar; 36(3):305-315. PubMed ID: 33368138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of lung adenocarcinoma from smoking and radiation arises in distinct molecular pathways.
    Castelletti N; Kaiser JC; Simonetto C; Furukawa K; Küchenhoff H; Stathopoulos GT
    Carcinogenesis; 2019 Oct; 40(10):1240-1250. PubMed ID: 30915466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Clinicopathological Characteristics and Tissue Inhibitor of Metalloproteinase-3 Polymorphism Rs9619311 on Biochemical Recurrence in Taiwanese Patients with Prostate Cancer.
    Hsieh CY; Lin CY; Wang SS; Chou YE; Chien MH; Wen YC; Hsieh MJ; Yang SF
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of clinicopathologic features on leptomeningeal metastasis from lung adenocarcinoma and treatment efficacy with epidermal growth factor receptor tyrosine kinase inhibitor.
    Kwon BS; Cho YH; Yoon SK; Lee DH; Kim SW; Kwon DH; Lee JC; Choi CM
    Thorac Cancer; 2020 Feb; 11(2):436-442. PubMed ID: 31910497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum EGFR gene mutation and serum tumor markers in predicting tyrosine kinase inhibitor efficacy in lung adenocarcinoma.
    Feng LX; Wang J; Yu Z; Song SA; Zhai WX; Dong SH; Yu HS; Zhang Y
    Clin Transl Oncol; 2019 Aug; 21(8):1005-1013. PubMed ID: 30637712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component.
    Kishi N; Ito M; Miyata Y; Kanai A; Handa Y; Tsutani Y; Kushitani K; Takeshima Y; Okada M
    Ann Surg Oncol; 2020 Mar; 27(3):945-955. PubMed ID: 31732945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of tissue inhibitor of metalloproteinases-3 genetic variants on clinicopathological characteristics of urothelial cell carcinoma.
    Weng WC; Hsieh MH; Chiou HL; Lee CY; Tang CH; Chang LC; Wang SS; Yang SF
    J Cancer; 2023; 14(3):360-366. PubMed ID: 36860920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLC.
    Yang S; Mao S; Li X; Zhao C; Liu Q; Yu X; Wang Y; Liu Y; Pan Y; Wang C; Gao G; Li W; Xiong A; Chen B; Sun H; He Y; Wu F; Chen X; Su C; Ren S; Zhou C
    Lung Cancer; 2020 Jan; 139():133-139. PubMed ID: 31786475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Immunological Landscape between
    Luo JW; Guo YH; Wu FY; Li XF; Sun XC; Wang JL; Zhou CC
    Dis Markers; 2021; 2021():3776854. PubMed ID: 34484468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element.
    Matsumura M; Okudela K; Kojima Y; Umeda S; Tateishi Y; Sekine A; Arai H; Woo T; Tajiri M; Ohashi K
    PLoS One; 2016; 11(11):e0166795. PubMed ID: 27861549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan.
    Chung JF; Chen CL; Nassef Y; Shiu BH; Wang CH; Kuo FH; Hsiao YH; Yang SF; Wang PH
    Int J Med Sci; 2022; 19(6):1013-1022. PubMed ID: 35813301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma.
    Chalela R; González-García JG; Khilzi K; Curull V; Sánchez-Font A; Longarón R; Rodrigo-Calvo MT; Martín-Ontiyuelo C; Gea J; Bellosillo B
    Pathol Oncol Res; 2021; 27():598292. PubMed ID: 34257550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
    Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
    Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific expression of MUC21 in micropapillary elements of lung adenocarcinomas - Implications for the progression of EGFR-mutated lung adenocarcinomas.
    Matsumura M; Okudela K; Nakashima Y; Mitsui H; Denda-Nagai K; Suzuki T; Arai H; Umeda S; Tateishi Y; Koike C; Kataoka T; Irimura T; Ohashi K
    PLoS One; 2019; 14(4):e0215237. PubMed ID: 30973916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.